JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawaguchi, K.
Right arrow Articles by Kobayashi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawaguchi, K.
Right arrow Articles by Kobayashi, K.
Journal of Clinical Microbiology, April 2003, p. 1701-1704, Vol. 41, No. 4
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.4.1701-1704.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Detection of Hepatitis B Virus DNA in Sera from Patients with Chronic Hepatitis B Virus Infection by DNA Microarray Method

Kazunori Kawaguchi, Shuichi Kaneko,* Masao Honda, Hiroshi F. Kawai, Yukihiro Shirota, and Kenichi Kobayashi

Gastroenterology, Kanazawa University Graduate School of Medical Science, Takara-Machi 13-1, Kanazawa 920-8641, Japan

Received 3 June 2002/ Returned for modification 29 September 2002/ Accepted 14 December 2002

We have developed a sensitive and quantitative assay using a DNA microarray for the detection of hepatitis B virus (HBV) DNA in serum. Fluorescently labeled target cDNA prepared from cloned HBV DNA or serum HBV DNA was hybridized to capture DNA on a slide. A linear relationship was obtained between the intensities of the array spot and the amount of the cloned or serum HBV DNA, indicating the quantitative accuracy of this assay system. In addition, there was a significant correlation between the number of molecules of serum HBV DNA determined by the DNA microarray and that determined by a branched-DNA assay (n = 21, r = 0.89). Given these results, we conclude that the DNA microarray assay system may be useful as a diagnostic technique in the clinical laboratory.


* Corresponding author. Mailing address: Gastroenterology, Kanazawa University Graduate School of Medical Science, Takara-Machi 13-1, Kanazawa 920-8641, Japan. Phone: 81-76-265-2231. Fax: 81-76-234-4250. E-mail: skaneko{at}medf.m.kanazawa-u.ac.jp.


Journal of Clinical Microbiology, April 2003, p. 1701-1704, Vol. 41, No. 4
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.4.1701-1704.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.